| 2026-04-23 | Dr. Dov A. GoldsteinCFO | 3,54k | 15,51k | Derivative Exercise and Retained Stock | 4,38 | 36,58k | 10,72% |
| 2026-04-01 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -8,82k | 112,51k | Derivative Exercise and Sale | 4,11 - 17,81 | 0,00 | - |
| 2026-03-02 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -7,43k | 115,42k | Derivative Exercise and Sale | 4,11 - 20,30 | - | - |
| 2026-03-01 | Dr. Dov A. GoldsteinCFO | 3,54k | 15,51k | Derivative Exercise and Retained Stock | 4,38 | 33,03k | 12,01% |
| 2026-02-02 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -7,43k | 103,90k | Derivative Exercise and Sale | 4,11 - 18,75 | 0,00 | - |
| 2026-02-01 | Dr. Dov A. GoldsteinCFO | 3,54k | 15,51k | Derivative Exercise and Retained Stock | 4,38 | 29,49k | 13,65% |
| 2026-01-16 | Dr. Dov A. GoldsteinCFO | 3,54k | 15,51k | Derivative Exercise and Retained Stock | 4,38 | 25,95k | 15,81% |
| 2026-01-13 | Dr. Dov A. GoldsteinCFO | -27,00k | 305,30k | Derivative Exercise and Sale | 8,39 - 21,08 | 22,41k | - |
| 2026-01-13 | Dr. Kristen FortneyCo-Founder, CEO, President, Treasurer, Secretary & Director | -233,11k | 4,22M | Automatic Disposition | 18,12 | 976,95k | -19,26% |
| 2026-01-02 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -7,43k | 60,02k | Derivative Exercise and Sale | 4,11 - 12,85 | 0,00 | - |
| 2025-12-09 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -18,00k | 97,74k | Derivative Exercise and Sale | 6,57 - 12,00 | 0,00 | - |
| 2025-12-04 | Dr. Paul D. RubinChief Medical Officer & Exec. VP of Research | -68,90k | 418,74k | Derivative Exercise and Sale | 4,11 - 10,19 | 0,00 | - |